$7.78 Billion is the total value of C WorldWide Group Holding A/S's 172 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 11.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| V | Sell | VISA INC | $1,177,866,000 | +7.2% | 7,847,732 | -5.4% | 15.13% | -0.8% |
| C | Sell | CITIGROUP INC | $355,079,000 | -19.8% | 4,949,524 | -25.2% | 4.56% | -25.8% |
| WFC | Sell | WELLS FARGO CO NEW | $311,629,000 | -5.3% | 5,928,999 | -0.1% | 4.00% | -12.4% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $142,366,000 | -13.8% | 864,076 | -3.0% | 1.83% | -20.3% |
| BIDU | Sell | BAIDU INCspon adr rep a | $56,087,000 | -8.4% | 245,265 | -2.6% | 0.72% | -15.2% |
| IBN | Sell | ICICI BK LTDadr | $44,792,000 | +2.7% | 5,275,920 | -2.9% | 0.58% | -5.0% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $42,278,000 | +4.7% | 158,916 | -3.5% | 0.54% | -3.0% |
| GILD | Sell | GILEAD SCIENCES INC | $16,454,000 | -5.6% | 213,104 | -13.4% | 0.21% | -12.8% |
| AGN | Sell | ALLERGAN PLC | $14,456,000 | +1.9% | 75,890 | -10.8% | 0.19% | -5.6% |
| ABBV | Sell | ABBVIE INC | $11,896,000 | -10.4% | 125,780 | -12.2% | 0.15% | -16.8% |
| ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $9,590,000 | +3.8% | 100,939 | -15.6% | 0.12% | -3.9% |
| MYL | Sell | MYLAN N V | $9,424,000 | -21.1% | 257,473 | -22.1% | 0.12% | -27.1% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $9,153,000 | -2.5% | 65,847 | -12.9% | 0.12% | -9.2% |
| NVCR | Sell | NOVOCURE LTD | $8,644,000 | +29.6% | 164,953 | -22.6% | 0.11% | +19.4% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $7,598,000 | -17.2% | 47,046 | -32.2% | 0.10% | -22.8% |
| EXAS | Sell | EXACT SCIENCES CORP | $7,306,000 | +8.4% | 92,572 | -17.9% | 0.09% | +1.1% |
| TSM | Sell | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $6,976,000 | +13.3% | 157,969 | -6.2% | 0.09% | +5.9% |
| HZNP | Sell | HORIZON PHARMA PLC | $6,879,000 | -0.0% | 351,349 | -15.4% | 0.09% | -7.4% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $6,767,000 | -44.2% | 545,715 | -31.3% | 0.09% | -48.2% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $6,664,000 | -11.0% | 108,266 | -2.3% | 0.09% | -17.3% |
| CARA | Sell | CARA THERAPEUTICS INC | $5,926,000 | +6.7% | 247,429 | -14.7% | 0.08% | -1.3% |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $5,679,000 | -14.4% | 208,182 | -15.6% | 0.07% | -20.7% |
| HRTX | Sell | HERON THERAPEUTICS INC | $5,643,000 | -31.2% | 178,283 | -15.5% | 0.07% | -36.8% |
| DXCM | Sell | DEX INC | $5,222,000 | -31.8% | 36,510 | -54.7% | 0.07% | -36.8% |
| LHCG | Sell | LHC GROUP INC | $5,254,000 | +4.6% | 51,016 | -13.0% | 0.07% | -4.3% |
| PRTK | Sell | PARATEK PHARMACEUTICALS INC | $4,930,000 | -9.9% | 508,282 | -5.2% | 0.06% | -17.1% |
| INSM | Sell | INSMED INC | $4,866,000 | -49.9% | 240,642 | -41.4% | 0.06% | -54.1% |
| XENT | Sell | INTERSECT ENT INC | $4,811,000 | -24.2% | 167,333 | -1.2% | 0.06% | -29.5% |
| DERM | Sell | DERMIRA INC | $4,445,000 | +0.3% | 407,771 | -15.3% | 0.06% | -6.6% |
| GKOS | Sell | GLAUKOS CORP | $4,303,000 | +37.2% | 66,307 | -14.1% | 0.06% | +25.0% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $3,760,000 | +0.5% | 227,896 | -14.7% | 0.05% | -7.7% |
| NUVA | Sell | NUVASIVE INC | $3,583,000 | -10.0% | 50,481 | -33.9% | 0.05% | -16.4% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $3,566,000 | -13.2% | 155,367 | -15.7% | 0.05% | -19.3% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $3,386,000 | -16.6% | 44,350 | -16.1% | 0.04% | -23.2% |
| NEO | Sell | NEOGENOMICS INC | $3,106,000 | -1.1% | 202,371 | -15.6% | 0.04% | -9.1% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,988,000 | -38.2% | 205,751 | -15.1% | 0.04% | -43.3% |
| STML | Sell | STEMLINE THERAPEUTICS INC | $2,978,000 | -13.2% | 179,409 | -16.0% | 0.04% | -20.8% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $2,677,000 | -44.7% | 91,156 | -14.3% | 0.03% | -49.3% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $2,581,000 | +22.0% | 158,996 | -3.1% | 0.03% | +13.8% |
| ACHC | Sell | ACADIA HEALTHCARE PANY IN | $2,561,000 | -27.6% | 72,767 | -15.8% | 0.03% | -32.7% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $2,524,000 | -33.9% | 55,048 | -14.8% | 0.03% | -39.6% |
| VCRA | Sell | VOCERA MUNICATIONS INC | $2,134,000 | +3.7% | 58,345 | -15.2% | 0.03% | -6.9% |
| PFNX | Sell | PFENEX INC | $1,800,000 | -8.4% | 352,153 | -3.0% | 0.02% | -14.8% |
| OTEX | Sell | OPEN TEXT CORP | $1,546,000 | -31.1% | 31,454 | -35.1% | 0.02% | -35.5% |
| BKI | Sell | BLACK KNIGHT INC | $1,533,000 | -24.7% | 29,500 | -22.4% | 0.02% | -28.6% |
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $1,255,000 | -56.4% | 18,102 | -52.5% | 0.02% | -60.0% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $1,182,000 | -29.6% | 23,473 | -16.3% | 0.02% | -34.8% |
| MA | Sell | MASTERCARD INCORPORATEDcl a | $1,046,000 | -14.1% | 4,700 | -24.2% | 0.01% | -23.5% |
| SBPH | Sell | SPRING BK PHARMACEUTICALS IN | $964,000 | -11.2% | 79,963 | -12.7% | 0.01% | -20.0% |
| SNA | Sell | SNAP ON INC | $923,000 | -48.1% | 5,030 | -54.5% | 0.01% | -52.0% |
| OBLN | Sell | OBALON THERAPEUTICS INC | $852,000 | +25.5% | 315,504 | -0.1% | 0.01% | +22.2% |
| ELGX | Sell | ENDOLOGIX INC | $588,000 | -71.5% | 307,976 | -15.5% | 0.01% | -72.4% |
| VLRX | Sell | VALERITAS HLDGS INC | $360,000 | -15.1% | 270,807 | -14.4% | 0.01% | -16.7% |
| VTVT | Exit | VTV THERAPEUTICS INCcl a | $0 | – | -48,185 | -100.0% | -0.00% | – |
| INGR | Exit | INGREDION INC | $0 | – | -8,254 | -100.0% | -0.01% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -18,947 | -100.0% | -0.02% | – |
| KMPH | Exit | KEMPHARM INC | $0 | – | -399,999 | -100.0% | -0.04% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -40,830 | -100.0% | -0.06% | – |
| KTWO | Exit | K2M GROUP HLDGS INC | $0 | – | -237,603 | -100.0% | -0.07% | – |
| PM | Exit | PHILIP MORRIS INTL INC | $0 | – | -2,670,730 | -100.0% | -2.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 37 | Q3 2023 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
| HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
| ICICI BK LTD | 37 | Q3 2023 | 2.1% |
| CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
| DEX INC | 37 | Q3 2023 | 0.5% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
| VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
| INSULET CORP | 37 | Q3 2023 | 0.3% |
| CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.